{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihqbqb66pbpyfcay4ukuo4ikw6n4dnj2rtdlzx7duvq6lc2mbmj3q",
    "uri": "at://did:plc:4kwqvtwyj7nywt3v7ra2cuy4/app.bsky.feed.post/3mfjjvykpiiw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibtg435gec3rc2vqeoyowrds3qeqprlvtzcsajkxax2tsauh4qnny"
    },
    "mimeType": "image/jpeg",
    "size": 142813
  },
  "path": "/content/979a4c4b-47f9-4b9f-894a-8ed7385c0b6a",
  "publishedAt": "2026-02-23T10:07:13.000Z",
  "site": "https://www.ft.com",
  "textContent": "Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments",
  "title": "Novo Nordisk shares drop 10% after poor weight loss trial result"
}